Global Exporter & Bulk Supplier of Ifoslieva 1g Injection

🌍 Introduction

Are you looking for a reliable, globally compliant exporter of Ifoslieva 1g Injection? At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, efficient, and high-standard distribution of critical oncology formulations. We supply Ifosfamide 1g injections to hospitals, specialized oncology clinics, and pharmaceutical wholesalers across the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Ifoslieva 1g Injection

Ifoslieva 1g Injection contains Ifosfamide, a potent alkylating agent used in various chemotherapy regimens to treat advanced malignancies.

• Composition: Ifosfamide 1g (per vial)

• Therapeutic Class: Alkylating Agent / Antineoplastic

• Formulation Type: Sterile powder for injection

• Storage: Store at room temperature (below 25°C). Reconstituted solutions should be used immediately.

⚙️ 2. Mechanism of Action

Ifoslieva works by interfering with the growth and spread of cancer cells in the body:

• DNA Cross-Linking: Ifosfamide is a "prodrug" that is activated by liver enzymes. Once active, it attaches to DNA strands within cancer cells.

• Replication Halt: By creating cross-links between DNA strands, it prevents the cancer cell from dividing and replicating its genetic material.

• Cell Death: This structural damage triggers programmed cell death (apoptosis), effectively shrinking tumors and slowing the progression of the disease.

🏥 3. Therapeutic Indications

Ifoslieva 1g Injection is clinically indicated for:

• Germ Cell Testicular Cancer: Typically used as third-line therapy in combination with other approved antineoplastic agents.

• Soft Tissue Sarcomas: Effective in treating various types of sarcomas in both adults and children.

• Lymphomas: Used in salvage regimens for Hodgkin’s and Non-Hodgkin’s lymphoma.

• Cervical & Ovarian Cancer: Frequently used in combination therapies for advanced cases.

⚠️ 4. Administration & Safety Guidelines

• Route: Administered only by Intravenous (IV) infusion by a qualified medical professional.

• Uroprotection: Often administered alongside Mesna to prevent hemorrhagic cystitis (bladder bleeding).

• Hydration: Maintaining high fluid intake is essential during treatment.

• Side Effects: Potential side effects include hair loss, nausea, vomiting, and myelosuppression (low blood counts).